SCHEMBL1710544

SCHEMBL1710544

CCCC(CCC)NS(=O)(=O)c1cccc(C=CCCC(N)=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
MMP2 P08253 2/20 0.37
MMP9 P14780 2/20 0.37
FBP1 P09467 2/20 0.36
HDAC3 O15379 7/20 0.36
HDAC4 P56524 7/20 0.36
HDAC1 Q13547 7/20 0.36
HDAC7 Q8WUI4 7/20 0.36
HDAC2 Q92769 7/20 0.36
HDAC10 Q969S8 7/20 0.36
HDAC11 Q96DB2 7/20 0.36
HDAC8 Q9BY41 7/20 0.36
HDAC6 Q9UBN7 7/20 0.36
HDAC9 Q9UKV0 7/20 0.36
HDAC5 Q9UQL6 7/20 0.36
BRD4 O60885 1/20 0.35
ESR1 P03372 1/20 0.35
PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1710540 1.00 CA1 (0.38) CA1CA2SMN1; SMN2MMP2MMP9
SCHEMBL3385274 0.84 SMN1; SMN2 (0.42) CA1CA2SMN1; SMN2FBP1HDAC3
SCHEMBL3385268 0.84 SMN1; SMN2 (0.42) CA1CA2SMN1; SMN2FBP1HDAC3
SCHEMBL1710542 0.81 SMN1; SMN2 (0.38) CA1CA2SMN1; SMN2MMP2MMP9
SCHEMBL3388394 0.78 CTSL (0.38) CA1CA2SMN1; SMN2FBP1HDAC3
SCHEMBL3388391 0.78 CTSL (0.38) CA1CA2SMN1; SMN2FBP1HDAC3
SCHEMBL1710642 0.69 SMN1; SMN2 (0.49) CA2SMN1; SMN2BRD4
SCHEMBL27821808 0.68 SMN1; SMN2 (0.72) CA1CA2SMN1; SMN2MMP2MMP9
SCHEMBL2541681 0.67 PAM (0.55) SMN1; SMN2HDAC3HDAC4HDAC1HDAC7
SCHEMBL1710532 0.66 HTR6 (0.51) CA1CA2SMN1; SMN2HTR6F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344451-A2 SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS Acucela, Inc. (US) 2011-07-20 EP disclosed